QUALITY CHALLENGES Rohan Patel Head of Quality Assurance

Slides:



Advertisements
Similar presentations
Project Quality Plans Gillian Sandilands Director of Quality
Advertisements

Nairobi, Kenya, 26 – 27July 2010 Maintaining Equipment Standards to ensure good QoS Mwende Njiraini Engineer I/NT/LCS Communications Commission of Kenya.
OPERATING EFFECTIVELY AT WESD. What is Internal Control? A process designed to provide reasonable assurance the organizations objectives are achieved.
Quality Assurance Policy RHSC, SSWG Addis Ababa, Ethiopia 21 June 2011 Morten Sorensen, UNFPA PSB.
Risk The chance of something happening that will have an impact on objectives. A risk is often specified in terms of an event or circumstance and the consequences.
Quality Management Training Quality circles Bench Mark Kaizen.
Medsafe – GMP update / release for supply / communicating quality issues Derek Fitzgerald Manager, Compliance Management 11 July 2013 RACI Pharmaceutical.
TM/WSP 5-9 Nov Group B2- Management - Human resources development - Financing - Electric grid, industrial inv. and procurement QUESTIONS / DIFFICULTIES.
Vetting and managing subcontractors – avoiding the bear traps Wayne Hughes HQN.
Audit of IT Systems SARQA / DKG Scandinavian Conference, October 2002, Copenhagen Sue Gregory.
Regulatory Compliant Performance Improvement for Pharmaceutical Plants AIChE New Jersey Section 01/13/2004 Murugan Govindasamy Pfizer Inc.
Quality Management.
What SMS means for an Operator’s relationship with the CAA
World Health Organization
The Regulatory Environment Legislation, Regulation and Enforcement Issues for Salt Iodization R. Houston – MOST/USAID Moldova Monitoring workshop April.
THE PRINCIPLES OF QUALITY MANAGEMENT. DEFINING QUALITY Good Appearance? High Price? The Best? Particular Specification? Not necessarily, but always: Fitness.
Personnel Basic Principles of GMP Workshop on
NATIONAL DRUG AUTHORITY - UGANDA | Slide 1 of February 2010, Geneva, Switzerland How the African NMRAs are benefiting from the WHO medicines prequalification.
ISO 9000 Introduction Imran Hussain.
Huzairy Hassan School of Bioprocess Engineering UniMAP.
A SOUND INVESTMENT IN SUCCESSFUL VR OUTCOMES FINANCIAL MANAGEMENT FINANCIAL MANAGEMENT.
Quality Control Testing in Procurement Helene Möller, M.Pharm, PhD Interregional Seminar for Quality Control Laboratories involved in WHO Prequalification.
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
Regulatory Overview.
Ashland Specialty Ingredients IFAC’s cGMP Audit Guide How the Food Ingredient Industry has Responded to FSMA and Food Safety Audits Priscilla Zawislak.
Recapture of Day 1 Suchart Chongprasert, Ph.D. Food and Drug Administration “Practical Aspects in Performing Clinical and Bioanalytical Parts in BA/BE.
ASEAN GMP TRAINING MODULE PERSONNEL
Building Quality Assurance into Clinical Trials. Objectives for Today: Define Quality in Research Describe How to Initiate Corrective and Preventative.
Ryve Prekorogja 13 June VET Vocational Education and Training.
1 Copyright © 2010 i3 | Recruitment, Retention and Motivation of your Team Louise Webber Associate Director, Statistical Programming, i3 Statprobe With.
InstantGMP: Electronic Batch Records System for GMP Manufacturing InstantGMP™ Inventory Control Module for GMP Manufacturing.
RPL as a strategic opportunity RTO good practice workshop 04/08 RPL as a strategic opportunity…  Introductions  RPL directions o Where are we now? 
Towards total systems human factors Dr Beverley Norris Human Factors Lead National Patient Safety Agency Dr Ken Catchpole Senior Post Doctoral Scientist.
Management Responsibilities. Building a Culture of Safety.
Q.A. in TRAINING Change Management Review The case Study of Banca CR Firenze Group Mario Spatafora DISSEMINATION CONFERENCE ATHENS 15th February 2008.
Important informations
“... now is the time to stop butting heads and start linking arms. It is not impossible to work out a united plan that will be acceptable for all, and.
Quality Assurance in Staff Development Training Seminar on Implementation of Effective Quality Assurance Systems in Romanian Higher Education Institutions.
Module 19 | Slide 1 of 14 January 2006 GMP Inspection Process Types of GMP Inspection.
WHO-Technical Briefing Seminar | October-November 2012 Dr Cécile Macé 1 |1 | Good Governance for Medicines Programme Dr Cécile Macé EMP/MPC.
Current Research in Public Procurement: A Global Perspective Khi V. Thai, Ph.D., Professor School of Public Administration Florida Atlantic University.
Responsibilities of Sponsor, Investigator and Monitor
Essential Requirements of Pool Management Companies
Pipeline Safety Management Systems
“Your sustainable compliance and remediation partners”
WHO Technical Briefing Seminar
Quality Control and Quality Assurance
GOOD MANUFACTURING PRACTICE FOR BIOPROCESS ENGINEERING (ERT 425)
“Quality assurance programme in EFI accredited laboratory in Novi Sad, Serbia” Svetlana Vojvodić MD.PhD. Institute for Blood Transfusion of Vojvodina.
Responsibilities of Sponsor, Investigator and Monitor
ISO/IEC
Pharmaceutical Quality Control & current Good Manufacturing Practice
EAST AFRICAN COMMUNITY MEDICINES REGULATORY HARMONIZATION (EAC-MRH) PROJECT PROGRESS NAIROB I - KENYA By: EAC - Secretariat.
WP 3 How to assess implementation of ALARA
Pennsylvania Ignition Interlock Program
Inter-Agency Guidelines for Good Procurement of Pharmaceuticals
The WHO Prequalification of Medicines Programme Capacity building agenda Dr Milan Smid.
Center for Veterinary Medicine Strategic Planning, 2002
You’ve bought a LIMS, now what?
GMP Inspection Process
The Regulatory Environment
GMP Inspection Process
Role of Industry Self-regulation in Phytosanitary Compliance
How to build your Integrated
Dr Manisha Shridhar Regional Advisor WHO-SEARO
Nicaragua and its position at the ITU's processes for assessing compliance and interoperability testing Ing. José Guillermo Valdivia Rojas Director of.
Prequalification of HIV/AIDS products and manufacturers
Technology Transfer to Africa Based Manufacturers
An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
Radiopharmaceutical Production
Presentation transcript:

QUALITY CHALLENGES Rohan Patel Head of Quality Assurance Cosmos Limited

Few of many Quality challenges Increasing International Regulatory Requirement CAPA Competition among local manufacturers Data Integrity WHO Pre-qualification

The Race for Quality has no finishing Line……… Increasing International Regulatory Requirement The Race for Quality has no finishing Line……… 1959 1978 1984 2004 2007 2008 2015 2017 Founder moved to Kenya to work as pharmacist Wholesale business acquisition Manufacturing start of essential drugs Construction of first site with expanded capacities GSK and BI voluntary license for ARV manufacturing USAID certification European PICS certification Construction of GMP tablet block Business expansion into African markets Market leadership in Kenya COSMOS Race towards achieving Quality Success. ----- -----

CAPA = COST = QUALITY IMPROVEMENT CORRECTIVE AND Preventive Action CAPA is much more than just “corrective actions” and “preventive actions”. Any opportunity to improve quality in any organization is a CAPA. Most Pharmaceutical QUALTIY SYSTEM triggers to CAPA. Corrective Action = Easy to handle (To immediate correct the situation). Preventive Action = Difficult to handle (To introduce new measures or To monitor the process for introducing new measures to prevent reoccurrence). CAPA = COST = QUALITY IMPROVEMENT

Competition among local manufacturers QUALITY Manufacturer’s against NON-QUALITY Manufacturer’s QUALITY Manufacturer’s try to upgrade their manufacturing plants by investing and implementing QMS while on the other side NON-QUALITY Manufacturer’s continue its manufacturing without QMS system. No motivation to QUALITY Manufacturer’s from local regulatory agency. COST of Production for QUALITY Manufacturer’s

DATA INTEGRITY Retaining Competent / Trained technical staff. Effective training to new entrants. Cultural training, mind-set corrections and moulding of newly recruited staff from other organisations into Quality Culture of company. Adherence to procedures and policies in place. Awareness and correct interpretation of regulations and cGMP requirements. 21 CFR PART 11 compliance Software and setting of different levels of user rights.

WHO Pre-qualification Cosmos is working towards WHO-PQ since 2012 and have successfully cleared safety and efficacy part of the dossier and we are now only 1 step behind in achieving the same i.e. Quality Part (Inspection). Since 2012, many challenges came across our way and we solved them by working as a team. Few challenges are still under progress and we are thinking before we implement what regulatory is asking, we should give a very deep thought and understand the regulatory requirements in order to avoid any future discrepancy. One of the challenge is Starting Material Coding: Does the material requires a specific code related to its manufacturer name, site of manufacturing and its specification? Or what if material code is related to only material and QA checks at different stages (i.e during procurement, receiving and sampling). Intention in either case is the same i.e. to get correct material form approved vendor. Hope, we will get some clarification from our trainers during this forum.

THANK You